BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 35371339)

  • 1. lncRNA LEF1-AS1 Acts as a Novel Biomarker and Promotes Hypopharyngeal Squamous Cell Carcinoma Progression and Metastasis by Targeting the miR-221-5p/GJA1 Axis.
    Fan J; Wang C; Zhai X; Li J; Ju J; Zhu Y; Zheng S; Ren N; Huang B; Jiang X; Xie Y; Zhao K; Liu M
    Dis Markers; 2022; 2022():3881310. PubMed ID: 35371339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Silencing of long noncoding RNA LEF1-AS1 prevents the progression of hepatocellular carcinoma via the crosstalk with microRNA-136-5p/WNK1.
    Dong H; Jian P; Yu M; Wang L
    J Cell Physiol; 2020 Oct; 235(10):6548-6562. PubMed ID: 32068261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long noncoding RNA LEF1-AS1 acts as a microRNA-10a-5p regulator to enhance MSI1 expression and promote chemoresistance in hepatocellular carcinoma cells through activating AKT signaling pathway.
    Gao J; Dai C; Yu X; Yin XB; Zhou F
    J Cell Biochem; 2021 Jan; 122(1):86-99. PubMed ID: 32786108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long noncoding RNA LEF1-AS1 silencing suppresses the initiation and development of prostate cancer by acting as a molecular sponge of miR-330-5p via LEF1 repression.
    Liu DC; Song LL; Liang Q; Hao L; Zhang ZG; Han CH
    J Cell Physiol; 2019 Aug; 234(8):12727-12744. PubMed ID: 30613973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of long non-coding RNA MALAT1 elevates microRNA-429 to suppress the progression of hypopharyngeal squamous cell carcinoma by reducing ZEB1.
    Liu X; Zhao W; Wang X
    Life Sci; 2020 Dec; 262():118480. PubMed ID: 32980391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long noncoding RNA
    Jiang Y; Wu K; Cao W; Xu Q; Wang X; Qin X; Wang X; Li Y; Zhang J; Chen W
    Epigenomics; 2020 Mar; 12(6):487-505. PubMed ID: 32267161
    [No Abstract]   [Full Text] [Related]  

  • 7. LEF1-AS1 is implicated in the malignant development of glioblastoma via sponging miR-543 to upregulate EN2.
    Zeng S; Zhou C; Yang DH; Xu LS; Yang HJ; Xu MH; Wang H
    Brain Res; 2020 Jun; 1736():146781. PubMed ID: 32184164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA DDX11 antisense RNA 1 promotes EMT process of esophageal squamous cell carcinoma by sponging miR-30d-5p to regulate SNAI1/ZEB2 expression and Wnt/β-catenin pathway.
    Guo Y; Sun P; Guo W; Yin Q; Han J; Sheng S; Liang J; Dong Z
    Bioengineered; 2021 Dec; 12(2):11425-11440. PubMed ID: 34866524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DLX6-AS1/miR-204-5p/OCT1 positive feedback loop promotes tumor progression and epithelial-mesenchymal transition in gastric cancer.
    Liang Y; Zhang CD; Zhang C; Dai DQ
    Gastric Cancer; 2020 Mar; 23(2):212-227. PubMed ID: 31463827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA TM4SF19-AS1 exacerbates cell proliferation, migration, invasion, and EMT in head and neck squamous cell carcinoma via enhancing LAMC1 expression.
    Yu Z; Wang X; Niu K; Sun L; Li D
    Cancer Biol Ther; 2022 Dec; 23(1):1-9. PubMed ID: 36411963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA TTN-AS1 promotes migration, invasion, and epithelial mesenchymal transition of lung adenocarcinoma via sponging miR-142-5p to regulate CDK5.
    Jia Y; Duan Y; Liu T; Wang X; Lv W; Wang M; Wang J; Liu L
    Cell Death Dis; 2019 Jul; 10(8):573. PubMed ID: 31363080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Knockdown of long non-coding RNA LEF1-AS1 attenuates apoptosis and inflammatory injury of microglia cells following spinal cord injury.
    Cui SY; Zhang W; Cui ZM; Yi H; Xu DW; Liu W; Zhu XH
    J Orthop Surg Res; 2021 Jan; 16(1):6. PubMed ID: 33407665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CREB1-induced lncRNA LEF1-AS1 contributes to colorectal cancer progression via the miR-489/DIAPH1 axis.
    Cheng Y; Wu J; Qin B; Zou BC; Wang YH; Li Y
    Biochem Biophys Res Commun; 2020 Jun; 526(3):678-684. PubMed ID: 32248974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncogenic Role of ZFAS1 lncRNA in Head and Neck Squamous Cell Carcinomas.
    Kolenda T; Guglas K; Kopczyńska M; Teresiak A; Bliźniak R; Mackiewicz A; Lamperska K; Mackiewicz J
    Cells; 2019 Apr; 8(4):. PubMed ID: 31010087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long noncoding RNA MEG3 decreases the growth of head and neck squamous cell carcinoma by regulating the expression of miR-421 and E-cadherin.
    Ji Y; Feng G; Hou Y; Yu Y; Wang R; Yuan H
    Cancer Med; 2020 Jun; 9(11):3954-3963. PubMed ID: 32277605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-coding RNA MFI2-AS1 promotes colorectal cancer cell proliferation, migration and invasion through miR-574-5p/MYCBP axis.
    Li C; Tan F; Pei Q; Zhou Z; Zhou Y; Zhang L; Wang D; Pei H
    Cell Prolif; 2019 Jul; 52(4):e12632. PubMed ID: 31094023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of lncRNA WWTR1-AS1 associates with tumor aggressiveness and unfavorable survival in head-neck squamous cell carcinoma.
    Li J; Li Z; Wu Y; Diao P; Zhang W; Wang Y; Yang J; Cheng J
    J Cell Biochem; 2019 Oct; 120(10):18266-18277. PubMed ID: 31172583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long non-coding RNA OIP5-AS1 serves as an oncogene in laryngeal squamous cell carcinoma by regulating miR-204-5p/ZEB1 axis.
    Wang H; Qian J; Xia X; Ye B
    Naunyn Schmiedebergs Arch Pharmacol; 2020 Nov; 393(11):2177-2184. PubMed ID: 32009213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. lncRNA
    Yang J; Lin X; Jiang W; Wu J; Lin L
    DNA Cell Biol; 2019 Sep; 38(9):1013-1021. PubMed ID: 31386568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long non-coding RNA SBF2-AS1 promotes hepatocellular carcinoma progression through regulation of miR-140-5p-TGFBR1 pathway.
    Li Y; Liu G; Li X; Dong H; Xiao W; Lu S
    Biochem Biophys Res Commun; 2018 Sep; 503(4):2826-2832. PubMed ID: 30115383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.